Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05467033RecruitingPhase 3
Desmopressin to improve safety after kidney biopsy
This trial tests whether desmopressin can make kidney biopsy safer by reducing bleeding risk. It compares safety outcomes after a biopsy in people who meet specific blood, medication, and health criteria.
BialystokAges 18–99 - NCT06491251Recruiting
Varicocele surgery for unexplained infertility in men
This trial tests whether surgery to remove a varicocele (enlarged veins in the scrotum) can help men with unexplained infertility and a normal sperm count become fathers. It's for men who have no other known cause of infertility.
Kafr ash ShaykhAges 18–45 - NCT06493812Recruiting
Comparing two tissue patches for pituitary tumor surgery
This trial compares two types of tissue patches (from the thigh or temple) used to repair the floor of the skull after pituitary tumor surgery. It helps prevent brain fluid leaks after the operation.
ZagrebAges 18 years+ - NCT07460752RecruitingPhase 2
Alternative injection site for goserelin in breast cancer patients
This trial is testing whether giving the drug goserelin in a different spot on the body works just as well for suppressing ovarian function in premenopausal women with hormone receptor positive breast cancer. You may be a fit if you've already been on goserelin shots in your abdomen for at least 6 months.
Rochester, MinnesotaAges 18–50 - NCT05536505RecruitingPhase 2
After-surgery targeted pill to prevent relapse in EGFR lung cancer
This Phase 2 trial studies whether an EGFR-targeted pill, given after surgery, can reduce the chance of lung cancer coming back. It specifically looks at people whose tumors have certain EGFR changes and where “minimal residual disease” (tiny leftover cancer) is being used to guide treatment.
BeijingAges 18–80 - NCT07461376Recruiting
A trial comparing two sleep medicines for children before surgery
This study tests two oral medicines given before surgery to help children relax and lower the need for stronger painkillers after the operation. It is for children having surgeries like hernia repair, circumcision, or hypospadias correction.
Cairo, Giza GovernorateAges 3–12 - NCT07465705RecruitingPhase 3
Comparing two bowel prep options for colonoscopy the same day
This trial compares two different bowel cleansing preparations taken the same day as your colonoscopy: mannitol vs Plenvu. It aims to see which one works best and is safe.
AnderlechtAges 18 years+ - NCT06479421Recruiting
AI study to personalize care for sudden breathing failure
This study is developing an artificial intelligence (AI) tool to help doctors choose the best treatment for people with sudden breathing failure. It compares patients who need breathing support to those who do not, to find patterns that improve care.
Seoul, GangnamAges 18 years+ - NCT06471855Recruiting
Rehabilitation support for leg amputation due to diabetes
This study is for people with diabetes or blood vessel disease who are at risk for losing a leg, have already had a lower leg amputation, or use a prosthetic leg. It focuses on a rehabilitation program that helps with both physical and emotional adjustment.
Pavia, PVAges Up to 80 years - NCT06457243Recruiting
Brain stimulation for methamphetamine use disorder
This trial tests a type of brain stimulation (called cTBS) to see if it can reduce methamphetamine cravings and improve thinking. If you are in recovery or still using, you may be able to join.
Shanghai, Shanghai MunicipalityAges 18–60 - NCT04708288Recruiting
Study of a dissolving bile-duct stent
This study tests a new type of stent that dissolves over time for the bile or pancreatic duct. It aims to see if the stent is safe and works well.
HelsinkiAges 18 years+ - NCT05654506RecruitingPhase 2
Daratumumab for kidney disease caused by immune deposits
This Phase 2 study tests daratumumab (an immune-targeting medicine) in people with PGNMID, a kidney disease where abnormal immune proteins build up in the kidney filters. It aims to reduce harmful protein in the urine and improve kidney health.
Jacksonville, FloridaAges 18 years+ - NCT06447584Recruiting
Poisoning in Children: Symptoms and Outcomes
This study looks at children who come to the hospital after being poisoned, to learn about their symptoms and how they recover. It may help doctors better treat poisoning emergencies in kids.
SohagAges 1 month–18 years - NCT06968234Recruiting
Liver disease breath test study
This study uses a special breath test to learn about chronic liver disease. If you have liver disease or cirrhosis, you may be able to help by providing a breath sample.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06404905RecruitingPhase 1
Testing BT02 for advanced solid tumors
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
Beijing, BiejingAges 18–75 - NCT06395441RecruitingPhase 3
Wisconsin ginseng for cancer-related fatigue
This trial tests whether Wisconsin ginseng can help reduce fatigue in people who have had or are getting treatment for a solid tumor cancer. It aims to improve energy levels and quality of life.
Albert Lea, MinnesotaAges 18 years+ - NCT06394622RecruitingPhase 1
CAR-NKT cells targeting CD70 for advanced solid tumors
This trial tests a new type of immune cell therapy (CAR-NKT) that targets a protein called CD70 on cancer cells. It is for people with advanced solid tumors that have not responded to at least two prior treatments and whose tumors are CD70-positive.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06386315RecruitingPhase 2
Lower dose radiation for slow-growing lymphoma
This trial tests whether giving a lower dose of radiation than usual works well for people with slow-growing B-cell lymphomas. It aims to reduce side effects while still controlling the disease.
Scottsdale, ArizonaAges 18 years+ - NCT06380738Recruiting
Real-world study of olaparib plus abiraterone for advanced prostate cancer
This trial is for people with advanced prostate cancer (mCRPC) who are already taking the combination of olaparib and abiraterone. It will look at how these two medicines work together in real-world practice.
AschaffenburgAges 18 years+ - NCT06383377Recruiting
New bone graft for tooth extraction and implant
This study tests a new bone graft material called Wishbone HA used after tooth extraction to prepare for a dental implant. It is for people who need a tooth pulled and have healthy gums and good bone support.
Louvain-la-Neuve, Brabant WallonAges 18–80 - NCT06382636Recruiting
Helping pregnant people make decisions about genetic testing
This study is for pregnant people who were offered prenatal genetic testing. It aims to help them make informed decisions about these tests, with the goal of improving pregnancy outcomes.
Cleveland, OhioAges 18–50 - NCT06380192Recruiting
Genetic Epilepsy and Development: A Natural History Study
This study looks at how a specific type of epilepsy with developmental challenges progresses over time. By reusing medical records, the researchers hope to learn more without extra hospital visits.
AmiensAges Any age - NCT06568549RecruitingPhase 4
Reducing Immunosuppression in Older Kidney Transplant Patients (RIOT Trial)
This trial tests whether older kidney transplant recipients can safely reduce their immunosuppression medications using a special monitoring tool called Trugraf. If you are over 55, have had a stable transplant, and want to possibly lower your medications, this study may be for you.
Phoenix, ArizonaAges 55 years+ - NCT06353191Recruiting
Blood markers to predict heart problems from cancer therapy
This study looks for early warning signs (biomarkers) of heart damage caused by cancer treatments. It is for people who have had cancer treatment, may have heart issues, or are about to start a treatment that could affect the heart.
Scottsdale, ArizonaAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,622 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.